Cue Biopharma Inc. (NASDAQ: CUE) Stock Information | RedChip

Cue Biopharma Inc. (NASDAQ: CUE)


$1.0300
-0.0100 ( +3.00% ) 123.6K

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Market Data


Open


$1.0300

Previous close


$1.0400

Volume


123.6K

Market cap


$62.72M

Day range


$0.9970 - $1.0600

52 week range


$0.4500 - $3.2000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 18, 2024
3 Insider transactions 2 Nov 29, 2024
4 Insider transactions 1 Nov 29, 2024
8-k 8K-related 13 Nov 14, 2024
10-q Quarterly Reports 79 Nov 14, 2024
8-k 8K-related 12 Oct 08, 2024
8-k 8K-related 12 Oct 04, 2024
8-k 8K-related 21 Sep 27, 2024
def Proxies and info statements 5 Sep 10, 2024
3 Insider transactions 2 Sep 05, 2024

Latest News